PROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat Cancer
Article in Molecular Cancer Therapeutics (January 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Anti-hepatocellular carcinoma activity of the cyclin-dependent kinase inhibitor AT7519
Article in Biomedicine & Pharmacotherapy (June 2023)
CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance via PSIP1/c-Myc Axis Nuclear Translocation and Partially through Increasing EGFR Expression
Preprint in Research Square (January 2023)